GALE variants associated with syndromic manifestations, macrothrombocytopenia, bleeding, and platelet dysfunction

References

• Chhay JS, Vargas CA, McCorvie TJ, Fridovich-Keil JL, Timson DJ. Analysis of UDP-galactose 4′-epimerase mutations associated with the intermediate form of type III galactosaemia. J Inherit Metab Dis. 2008;31(1):108–8. doi:10.1007/s10545-007-0790-9.
   PubMed Web of Science ®Google Scholar
• Demirbas D, Coelho AI, Rubio-Gozalbo ME, Berry GT. Hereditary galactosemia. Metabolism. 2018;83(2018):188–196. doi:10.1016/j.metabol.2018.01.025.
   PubMedGoogle Scholar
• Fridovich-Keil J, Bean L, He M, et al. Epimerase deficiency galactosemia. In: Adam MP, Everman DB, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 2011 Jan 25 [Updated 2021 Mar 4]. p. 1993–2023.
   Google Scholar
• Broussard A, Florwick A, Desbiens C, Nischan N, Robertson C, Guan Z, Kohler JJ, Wells L, Boyce M. Human UDP-galactose 4′-epimerase (GALE) is required for cell-surface glycome structure and function. J Biol Chem. 2020;295(5):1225–1239. doi:10.1016/S0021-9258(17)49882-6.
   PubMed Web of Science ®Google Scholar
• Marín-Quílez A, Di Buduo CA, Díaz-Ajenjo L, Abbonante V, Vuelta E, Soprano PM, Miguel-García C, Santos-Mínguez S, Serramito-Gómez I, Ruiz-Sala P, Peñarrubia MJ, Pardal E, Hernández-Rivas JM, González-Porras JR, García-Tuñón I, Benito R, Rivera J, Balduini A, Bastida JM. Novel variants in GALE cause syndromic macrothrombocytopenia by disrupting glycosylation and thrombopoiesis. Blood. 2023 Jan 26;141(4):406–421. doi:10.1182/blood.2022016995.
   PubMed Web of Science ®Google Scholar
• Alano A, Almashanu S, Maceratesi P, Reichardt J, Panny S, Cowan TM. UDP-galactose-4-epimerase deficiency among African-Americans: evidence for multiple alleles. J Invest Med. 1997;5:191A.
   Google Scholar
• Gitzelmann R. Deficiency of uridine diphosphate galactose 4-epimerase in blood cells of an apparently healthy infant. Preliminary communication. Helv Paediatr Acta. 1972;27(2):125–130.
   PubMedGoogle Scholar
• Dias Costa F, Ferdinandusse S, Pinto C, Dias A, Keldermans L, Quelhas D, Matthijs G, Mooijer PA, Diogo L, Jaeken J, et al. Galactose epimerase deficiency: expanding the phenotype. JIMD Rep. 2017;37:19–25.
   PubMedGoogle Scholar
• Febres-Aldana CA, Pelaez L, Wright MS, Maher OM, Febres-Aldana AJ, Sasaki J, Jayakar P, Jayakar A, Diaz-Barbosa M, Janvier M, et al. A case of udp-galactose 4′-epimerase deficiency associated with dyshematopoiesis and atrioventricular valve malformations: an exceptional clinical phenotype explained by altered n-glycosylation with relative preservation of the leloir pathway. Mol Syndromol. 2020;11(5–6):320–330. doi:10.1159/000511343
   PubMed Web of Science ®Google Scholar
• Markovitz R, Owen N, Satter LF, Kirk S, Mahoney DH, Bertuch AA, Scaglia F. Expansion of the clinical phenotype of GALE deficiency. Am J Med Genet Part A. 2021;185(10):3118–3121. doi:10.1002/ajmg.a.62384.
   PubMed Web of Science ®Google Scholar
• McCorvie TJ, Wasilenko J, Liu Y, Fridovich-Keil JL, Timson DJ. In vivo and in vitro function of human UDP-galactose 4′-epimerase variants. Biochimie. 2011;93(10):1747–1754. doi:10.1016/j.biochi.2011.06.009.
   PubMed Web of Science ®Google Scholar
• Openo KK, Schulz JM, Vargas CA, Orton CS, Epstein MP, Schnur RE, Scaglia F, Berry GT, Gottesman GS, Ficicioglu C, et al. Epimerase-deficiency galactosemia is not a binary condition. Am J Hum Genet. 2006;78(1):89–102. doi:10.1086/498985
   PubMed Web of Science ®Google Scholar
• Timson DJ. Functional analysis of disease-causing mutations in human UDP-galactose 4-epimerase. FEBS J. 2005;272(23):6170–6177. doi:10.1111/j.1742-4658.2005.05017.x.
   PubMed Web of Science ®Google Scholar
• Alano A, Almashanu S, Chinsky JM, Costeas P, Blitzer MG, Wulfsberg EA, Cowan TM. Molecular characterization of a unique patient with epimerase-deficiency galactosaemia. J Inherit Metab Dis. 1998;21(4):341–350. doi:10.1023/A:1005342306080.
   PubMed Web of Science ®Google Scholar
• Quimby BB, Alano A, Almashanu S, DeSandro AM, Cowan TM, Fridovich-Keil JL. Characterization of two mutations associated with epimerase-deficiency galactosemia, by use of a yeast expression system for human UDP-galactose-4- epimerase. Am J Hum Genet. 1997;61(3):590–598. doi:10.1086/515517.
   PubMed Web of Science ®Google Scholar
• Seo A, Gulsuner S, Pierce S, Ben-Harosh M, Shalev H, Walsh T, Krasnov T, Dgany O, Doulatov S, Tamary H, et al. Inherited thrombocytopenia associated with mutation of UDP-galactose-4-epimerase (GALE). Hum Mol Genet. 2019;28(1):133–142. doi:10.1093/hmg/ddy334
   PubMed Web of Science ®Google Scholar
• Wohlers TM, Christacos NC, Harreman MT, Fridovich-Keil JL. Identification and characterization of a mutation, in the human UDP-galactose-4-epimerase gene, associated with generalized epimerase-deficiency galactosemia. Am J Hum Genet. 1999;64(2):462–470. doi:10.1086/302263.
   PubMed Web of Science ®Google Scholar
• Wohlers TM, Fridovich-Keil JL. Studies of the V94M-substituted human UDPgalactose-4-epimerase enzyme associated with generalized epimerase-deficiency galactosaemia. J Inherit Metab Dis. 2000;23(7):713–729. doi:10.1023/A:1005682913784.
   PubMed Web of Science ®Google Scholar
• Timson DJ, Lindert S. Comparison of dynamics of wildtype and V94M human UDP-galactose 4-epimerase-A computational perspective on severe epimerase-deficiency galactosemia. Gene. 2013;526(2):318–324.
   PubMed Web of Science ®Google Scholar
• Liu Y, Bentler K, Coffee B, Chhay JS, Sarafoglou K, Fridovich-Keil JL. A case study of monozygotic twins apparently homozygous for a novel variant of UDP-Galactose 4′-epimerase (GALE): a complex case of variant GALE. JIMD Rep. 2013;7:89–98.
   PubMedGoogle Scholar
• Bang YL, Nguyen TTT, Trinh TTB, Kim YJ, Song J, Song YH. Functional analysis of mutations in UDP-galactose-4-epimerase (GALE) associated with galactosemia in Korean patients using mammalian GALE-null cells. FEBS J. 2009;276(7):1952–1961. doi:10.1111/j.1742-4658.2009.06922.x.
   PubMed Web of Science ®Google Scholar
• Rosoff PM. Myelodysplasia and deficiency of uridine diphosphate-galactose 4-epimerase. J Pediatr. 1995;127(4):605–608. doi:10.1016/S0022-3476(95)70124-9.
   PubMed Web of Science ®Google Scholar
• Kingsley DM, Kozarsky KF, Hobble L, Krieger M. Reversible defects in O-linked glycosylation and LDL receptor expression in a UDP-Gal UDP-GalNAc 4-epimerase deficient mutant. Cell. 1986;44(5):749–759. doi:10.1016/0092-8674(86)90841-X.
   PubMed Web of Science ®Google Scholar
• McCorvie TJ, Timson DJ. In silico prediction of the effects of mutations in the human UDP-galactose 4’-epimerase gene: towards a predictive framework for type III galactosemia. Gene. 2013;524(2):95–104. doi:10.1016/j.gene.2013.04.061.
   PubMed Web of Science ®Google Scholar